BRIEF-Liminatus Pharma Enters Settlement Agreement With Clear Street LLC

Reuters

Feb 10

Feb 9 (Reuters) - Liminatus Pharma Inc LIMN.O:

LIMINATUS PHARMA INC - ON FEB 6, CO ENTERS SETTLEMENT AGREEMENT WITH CLEAR STREET LLC - SEC FILING
LIMINATUS PHARMA INC - TO ISSUE 4 MILLION SHARES OF COMMON STOCK TO HOLDER IN EXCHANGE FOR SURRENDER AND CANCELLATION OF 805,377 WARRANTS

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2610265663"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2610265663\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2610265663?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-10 04:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2610265663","market":"us","top_or_hot":-1,"title":"BRIEF-Liminatus Pharma Enters Settlement Agreement With Clear Street LLC","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Liminatus Pharma Enters Settlement Agreement With Clear Street LLC</title></head><body><p><span>Feb 9 (Reuters)</span><span> - </span>Liminatus Pharma Inc <span>LIMN.O</span>:</p><ul><li><p>LIMINATUS PHARMA INC - ON FEB 6, CO ENTERS SETTLEMENT AGREEMENT WITH CLEAR STREET LLC - SEC FILING</p></li><li><p>LIMINATUS PHARMA INC - TO ISSUE 4 MILLION SHARES OF COMMON STOCK TO HOLDER IN EXCHANGE FOR SURRENDER AND CANCELLATION OF 805,377 WARRANTS</p></li></ul><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Liminatus Pharma Enters Settlement Agreement With Clear Street LLC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Liminatus Pharma Enters Settlement Agreement With Clear Street LLC\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-10 04:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Liminatus Pharma Enters Settlement Agreement With Clear Street LLC</title></head><body><p><span>Feb 9 (Reuters)</span><span> - </span>Liminatus Pharma Inc <span>LIMN.O</span>:</p><ul><li><p>LIMINATUS PHARMA INC - ON FEB 6, CO ENTERS SETTLEMENT AGREEMENT WITH CLEAR STREET LLC - SEC FILING</p></li><li><p>LIMINATUS PHARMA INC - TO ISSUE 4 MILLION SHARES OF COMMON STOCK TO HOLDER IN EXCHANGE FOR SURRENDER AND CANCELLATION OF 805,377 WARRANTS</p></li></ul><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LIMN","symbol_name":"Liminatus Pharma LLC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z50RG:1","article_id":"2610265663","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2610265663","pubTimestamp":1770667567,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Liminatus Pharma Enters Settlement Agreement With Clear Street LLCFeb 9  - Liminatus Pharma Inc LIMN.O:LIMINATUS PHARMA INC - ON FEB 6, CO ENTERS SETTLEMENT AGREEMENT WITH CLEAR STREET LLC - SEC FILINGLIMINATUS PHARMA INC - TO ISSUE 4 MILLION SHARES OF COMMON STOCK TO HOLDER IN EXCHANGE FOR SURRENDER AND CANCELLATION OF 805,377 WARRANTS ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LIMN":"Liminatus Pharma LLC","BK4139":"生物科技"},"translate_title":"简介-Liminatus Pharma与Clear Street LLC达成和解协议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LIMN":0.9},"content_text":"BRIEF-Liminatus Pharma Enters Settlement Agreement With Clear Street LLCFeb 9 (Reuters) - Liminatus Pharma Inc LIMN.O:LIMINATUS PHARMA INC - ON FEB 6, CO ENTERS SETTLEMENT AGREEMENT WITH CLEAR STREET LLC - SEC FILINGLIMINATUS PHARMA INC - TO ISSUE 4 MILLION SHARES OF COMMON STOCK TO HOLDER IN EXCHANGE FOR SURRENDER AND CANCELLATION OF 805,377 WARRANTS ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}